iDtheinvestordatabase
Home / Directory / Oxford Science Enterprises
Likely active: portfolio news Mar 2026 Verified 4 Nov 2026

Oxford Science Enterprises

Independent investment company and venture builder, founded in 2015 with a strategic partnership with the University of Oxford. Creates and funds companies from Oxford, Harwell and Culham science across deep tech, life sciences and health tech, from pre-seed to growth.

Type
VC firm
Location
Oxford, United Kingdom
Stages
Pre-seed, Seed, Series A, Series B, Growth
Backs
Medtech and digital health, Biotech and pharma, Deep tech
Sectors
Healthtech and life sciences, AI, Biotech, Deep tech, Climate and cleantech
Fund size / AUM
£1.4bn net asset value; over £850m raised from shareholders
Portfolio mix
Medtech and digital health 28%; Biotech and pharma 24%; Deep tech 17%; B2B software 10%; Climate and energy 10%; Hardware 7%; Real assets 3% (n=30)

Contacts on file

For Oxford Science Enterprises, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); how to pitch (the route the firm publishes); LinkedIn page.

Get UK Complete, $149 Free sample

One-time payment. No subscription. No account.

Notable investments

Oxford IonicsOMass TherapeuticsSalience LabsUltromicsWild Bioscience

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 54 lists

Series B investors in the UK (54)Series B medtech investors (57)Medtech investors in the UK (58)Series B biotech investors (73)Biotech investors in the UK (92)Series B climate tech investors (98)Growth-stage medtech investors (107)Growth-stage biotech investors (109)Series B deep tech investors (113)Series A medtech investors (125)Pre-seed medtech investors (129)Deep tech investors in the UK (135)Growth-stage investors in the UK (137)Climate tech investors in the UK (146)Pre-seed biotech investors (148)Series A biotech investors (153)Series A investors in the UK (154)Series B healthtech investors (160)Pre-seed investors in the UK (175)Growth-stage climate tech investors (189)Growth-stage deep tech investors (191)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Series B AI investors (204)AI investors in the UK (214)Pre-seed climate tech investors (230)Series A climate tech investors (263)Seed medtech investors (278)Series A deep tech investors (293)Seed investors in the UK (295)Growth-stage AI investors (295)Seed biotech investors (300)Growth-stage healthtech investors (316)Pre-seed deep tech investors (316)Series B investors (339)Series A healthtech investors (401)Pre-seed healthtech investors (408)Startup investors in the UK (416)Medtech investors (457)Seed climate tech investors (458)Biotech investors (484)Series A AI investors (500)Seed deep tech investors (555)Pre-seed AI investors (633)Climate tech investors (660)Growth-stage investors (705)Deep tech investors (763)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Seed AI investors (1,082)Healthtech investors (1,207)AI investors (1,576)Seed investors (1,892)